Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Neurosci
2015 Nov 11;3545:14957-65. doi: 10.1523/JNEUROSCI.1597-15.2015.
Show Gene links
Show Anatomy links
GIRK Channels Mediate the Nonphotic Effects of Exogenous Melatonin.
Hablitz LM
,
Molzof HE
,
Abrahamsson KE
,
Cooper JM
,
Prosser RA
,
Gamble KL
.
???displayArticle.abstract???
Melatonin supplementation has been used as a therapeutic agent for several diseases, yet little is known about the underlying mechanisms by which melatonin synchronizes circadian rhythms. G-protein signaling plays a large role in melatonin-induced phase shifts of locomotor behavior and melatonin receptors activate G-protein-coupled inwardly rectifying potassium (GIRK) channels in Xenopus oocytes. The present study tested the hypothesis that melatonin influences circadian phase and electrical activity within the central clock in the suprachiasmatic nucleus (SCN) through GIRK channel activation. Unlike wild-type littermates, GIRK2 knock-out (KO) mice failed to phase advance wheel-running behavior in response to 3 d subcutaneous injections of melatonin in the late day. Moreover, in vitro phase resetting of the SCN circadian clock by melatonin was blocked by coadministration of a GIRK channel antagonist tertiapin-q (TPQ). Loose-patch electrophysiological recordings of SCN neurons revealed a significant reduction in the average action potential rate in response to melatonin. This effect was lost in SCN slices treated with TPQ and SCN slices from GIRK2 KO mice. The melatonin-induced suppression of firing rate corresponded with an increased inward current that was blocked by TPQ. Finally, application of ramelteon, a potent melatonin receptor agonist, significantly decreased firing rate and increased inward current within SCN neurons in a GIRK-dependent manner. These results are the first to show that GIRK channels are necessary for the effects of melatonin and ramelteon within the SCN. This study suggests that GIRK channels may be an alternative therapeutic target for diseases with evidence of circadian disruption, including aberrant melatonin signaling.
SIGNIFICANCE STATEMENT: Despite the widespread use of melatonin supplementation for the treatment of sleep disruption and other neurological diseases such as epilepsy and depression, no studies have elucidated the molecular mechanisms linking melatonin-induced changes in neuronal activity to its therapeutic effects. Here, we used behavioral and electrophysiological techniques to address this scientific gap. Our results show that melatonin and ramelteon, a potent and clinically relevant melatonin receptor agonist, significantly affect the neurophysiological function of suprachiasmatic nucleus neurons through activation of G-protein-coupled inwardly rectifying potassium (GIRK) channels. Given the importance of GIRK channels for neuronal excitability (with >600 publications on these channels to date), our study should generate broad interest from neuroscientists in fields such as epilepsy, addiction, and cognition.
Agez,
Melatonin affects nuclear orphan receptors mRNA in the rat suprachiasmatic nuclei.
2007, Pubmed
Agez,
Melatonin affects nuclear orphan receptors mRNA in the rat suprachiasmatic nuclei.
2007,
Pubmed
Agez,
Endogenous melatonin provides an effective circadian message to both the suprachiasmatic nuclei and the pars tuberalis of the rat.
2009,
Pubmed
Arora,
Acute cocaine exposure weakens GABA(B) receptor-dependent G-protein-gated inwardly rectifying K+ signaling in dopamine neurons of the ventral tegmental area.
2011,
Pubmed
Banach,
Melatonin in experimental seizures and epilepsy.
2011,
Pubmed
Benloucif,
Melatonin and light induce phase shifts of circadian activity rhythms in the C3H/HeN mouse.
1996,
Pubmed
Besing,
Neuropeptide Y-induced phase shifts of PER2::LUC rhythms are mediated by long-term suppression of neuronal excitability in a phase-specific manner.
2012,
Pubmed
Biello,
Circadian clock resetting in the mouse changes with age.
2009,
Pubmed
Bonnefont-Rousselot,
Melatonin: action as antioxidant and potential applications in human disease and aging.
2010,
Pubmed
Borja,
Ramelteon for the treatment of insomnia.
2006,
Pubmed
Campos Costa,
Aging, circadian rhythms and depressive disorders: a review.
2013,
Pubmed
Challet,
Minireview: Entrainment of the suprachiasmatic clockwork in diurnal and nocturnal mammals.
2007,
Pubmed
Cho,
Molecular mechanism of circadian rhythmicity of seizures in temporal lobe epilepsy.
2012,
Pubmed
Churchill,
Sleep measurement and monitoring in children with Down syndrome: a review of the literature, 1960-2010.
2012,
Pubmed
Comai,
Unveiling the role of melatonin MT2 receptors in sleep, anxiety and other neuropsychiatric diseases: a novel target in psychopharmacology.
2014,
Pubmed
Coomans,
The suprachiasmatic nuclei as a seasonal clock.
2015,
Pubmed
Dubocovich,
Functional MT1 and MT2 melatonin receptors in mammals.
2005,
Pubmed
Dubocovich,
Molecular pharmacology, regulation and function of mammalian melatonin receptors.
2003,
Pubmed
Dubocovich,
Effect of MT1 melatonin receptor deletion on melatonin-mediated phase shift of circadian rhythms in the C57BL/6 mouse.
2005,
Pubmed
Dubocovich,
Melatonin receptors: role on sleep and circadian rhythm regulation.
2007,
Pubmed
Fowler,
Evidence for association of GABA(B) receptors with Kir3 channels and regulators of G protein signalling (RGS4) proteins.
2007,
Pubmed
Fu,
Neuropeptide Y inhibits hypocretin/orexin neurons by multiple presynaptic and postsynaptic mechanisms: tonic depression of the hypothalamic arousal system.
2004,
Pubmed
Furuya,
Marked improvement in delirium with ramelteon: five case reports.
2012,
Pubmed
García,
Protective effects of melatonin in reducing oxidative stress and in preserving the fluidity of biological membranes: a review.
2014,
Pubmed
Hablitz,
Suprachiasmatic nucleus function and circadian entrainment are modulated by G protein-coupled inwardly rectifying (GIRK) channels.
2014,
Pubmed
Hastings,
Non-photic phase shifting of the circadian activity rhythm of Syrian hamsters: the relative potency of arousal and melatonin.
1992,
Pubmed
Hatta,
Preventive effects of ramelteon on delirium: a randomized placebo-controlled trial.
2014,
Pubmed
Huhman,
Neuropeptide Y microinjected into the suprachiasmatic region phase shifts circadian rhythms in constant darkness.
1994,
Pubmed
Hunt,
Activation of MT(2) melatonin receptors in rat suprachiasmatic nucleus phase advances the circadian clock.
2001,
Pubmed
Jain,
Does melatonin affect epileptic seizures?
2013,
Pubmed
Jiang,
Melatonin activates an outward current and inhibits Ih in rat suprachiasmatic nucleus neurons.
1995,
Pubmed
Kato,
Neurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist.
2005,
Pubmed
Kaufmann,
ML297 (VU0456810), the first potent and selective activator of the GIRK potassium channel, displays antiepileptic properties in mice.
2013,
Pubmed
Kobayashi,
G protein-activated inwardly rectifying potassium channels as potential therapeutic targets.
2006,
Pubmed
Kuhlman,
Rhythmic regulation of membrane potential and potassium current persists in SCN neurons in the absence of environmental input.
2004,
Pubmed
Laudon,
Therapeutic effects of melatonin receptor agonists on sleep and comorbid disorders.
2014,
Pubmed
Liu,
Molecular dissection of two distinct actions of melatonin on the suprachiasmatic circadian clock.
1997,
Pubmed
Loddenkemper,
Circadian patterns of pediatric seizures.
2011,
Pubmed
Lott,
Neurological phenotypes for Down syndrome across the life span.
2012,
Pubmed
Luchetti,
Melatonin signaling and cell protection function.
2010,
Pubmed
Lüscher,
Emerging roles for G protein-gated inwardly rectifying potassium (GIRK) channels in health and disease.
2010,
Pubmed
McArthur,
Melatonin directly resets the rat suprachiasmatic circadian clock in vitro.
1991,
Pubmed
McArthur,
Melatonin action and signal transduction in the rat suprachiasmatic circadian clock: activation of protein kinase C at dusk and dawn.
1997,
Pubmed
Miyamoto,
Pharmacology of ramelteon, a selective MT1/MT2 receptor agonist: a novel therapeutic drug for sleep disorders.
2009,
Pubmed
Mundey,
Phase-dependent treatment of delayed sleep phase syndrome with melatonin.
2005,
Pubmed
Muraki,
Serotonergic regulation of the orexin/hypocretin neurons through the 5-HT1A receptor.
2004,
Pubmed
Nelson,
Melatonin receptors activate heteromeric G-protein coupled Kir3 channels.
1996,
Pubmed
,
Xenbase
Parekh,
Circadian clock genes: effects on dopamine, reward and addiction.
2015,
Pubmed
Partch,
Molecular architecture of the mammalian circadian clock.
2014,
Pubmed
Paulis,
Cardiovascular effects of melatonin receptor agonists.
2012,
Pubmed
Poirel,
Contrary to other non-photic cues, acute melatonin injection does not induce immediate changes of clock gene mRNA expression in the rat suprachiasmatic nuclei.
2003,
Pubmed
Prosser,
Melatonin inhibits in vitro serotonergic phase shifts of the suprachiasmatic circadian clock.
1999,
Pubmed
Prosser,
Serotonin phase-shifts the mouse suprachiasmatic circadian clock in vitro.
2003,
Pubmed
Prosser,
Neuropeptide Y blocks serotonergic phase shifts of the suprachiasmatic circadian clock in vitro.
1998,
Pubmed
Racagni,
The interaction between the internal clock and antidepressant efficacy.
2007,
Pubmed
Ramgopal,
Chronopharmacology of anti-convulsive therapy.
2013,
Pubmed
Rawashdeh,
Circadian periods of sensitivity for ramelteon on the onset of running-wheel activity and the peak of suprachiasmatic nucleus neuronal firing rhythms in C3H/HeN mice.
2011,
Pubmed
Rivera-Bermúdez,
Immortalized cells from the rat suprachiasmatic nucleus express functional melatonin receptors.
2004,
Pubmed
Rivera-Bermúdez,
Regulation of basal rhythmicity in protein kinase C activity by melatonin in immortalized rat suprachiasmatic nucleus cells.
2003,
Pubmed
Roenneberg,
Circadian clocks - the fall and rise of physiology.
2005,
Pubmed
Ruiz de Elvira,
Use of running wheels regulates the effects of the ovaries on circadian rhythms.
1992,
Pubmed
Schaap,
Neurons of the rat suprachiasmatic nucleus show a circadian rhythm in membrane properties that is lost during prolonged whole-cell recording.
1999,
Pubmed
Scott,
Electrophysiological effects of melatonin on mouse Per1 and non-Per1 suprachiasmatic nuclei neurones in vitro.
2010,
Pubmed
Shimomura,
Genetic suppression of the circadian Clock mutation by the melatonin biosynthesis pathway.
2010,
Pubmed
Signorini,
Normal cerebellar development but susceptibility to seizures in mice lacking G protein-coupled, inwardly rectifying K+ channel GIRK2.
1997,
Pubmed
Siuciak,
Autoradiographic localization of 2-[125I]iodomelatonin binding sites in the brains of C3H/HeN and C57BL/6J strains of mice.
1990,
Pubmed
Srinivasan,
Role of melatonin in mood disorders and the antidepressant effects of agomelatine.
2012,
Pubmed
Stores,
Sleep disorders and their clinical significance in children with Down syndrome.
2013,
Pubmed
Turek,
Effects of age on the circadian system.
1995,
Pubmed
Uberos,
Melatonin and elimination of kynurenines in children with Down's syndrome.
2010,
Pubmed
Vyazovskiy,
Sleep and rest regulation in young and old oestrogen-deficient female mice.
2006,
Pubmed
Webb,
Diurnal and circadian regulation of reward-related neurophysiology and behavior.
2015,
Pubmed
Wu,
Alterations of melatonin receptors MT1 and MT2 in the hypothalamic suprachiasmatic nucleus during depression.
2013,
Pubmed
Wydeven,
Mechanisms underlying the activation of G-protein-gated inwardly rectifying K+ (GIRK) channels by the novel anxiolytic drug, ML297.
2014,
Pubmed
Zarowski,
Circadian distribution and sleep/wake patterns of generalized seizures in children.
2011,
Pubmed
Zhou,
Modulation of circadian rhythm of discharges of suprachiasmatic nucleus neurons in rat hypothalamic slices by melatonin.
2000,
Pubmed
van den Pol,
Neuropeptide transmission in brain circuits.
2012,
Pubmed
van den Top,
Melatonin generates an outward potassium current in rat suprachiasmatic nucleus neurones in vitro independent of their circadian rhythm.
2001,
Pubmed
